Robotic vs Laparoscopic Cholecystectomy: JAMA Surgery | July 2026

Introduction:

Robotic cholecystectomy continues to expand worldwide, but its value compared with conventional laparoscopy remains debated. This large study evaluated whether the robotic platform offers meaningful clinical or economic advantages in complex versus routine elective cholecystectomy.

Why was this study needed?

• The clinical value of robotic cholecystectomy remains controversial.
• Most previous studies have not differentiated between routine and complex gallbladder disease.
• The higher cost of robotic surgery raises concerns regarding value-based care.
• Better evidence is needed to identify patients who truly benefit from robotics.
• Selective use of robotic surgery may improve outcomes while optimizing healthcare resources.

Results:

• Robotic surgery significantly reduced postoperative biliary and interventional radiology procedures in patients undergoing complex elective cholecystectomy.
• Although robotic surgery had higher operating room costs, the overall cost of care was comparable because of fewer postoperative complications and interventions.
• In routine (non-complex) cholecystectomy, robotic surgery did not improve clinical outcomes and was associated with higher overall costs.

Clinical Impact:

These findings support a selective rather than routine use of robotic cholecystectomy. The robotic platform appears to provide the greatest value in technically challenging gallbladder disease, while conventional laparoscopy remains the preferred approach for standard-risk patients.

Bottom Line:

The value of robotic cholecystectomy depends on case complexity. For complex gallbladder disease, robotics may improve outcomes without increasing overall healthcare costs. For routine cholecystectomy, conventional laparoscopy remains the more cost-effective standard of care.